{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:42:10Z","timestamp":1793162530698,"version":"4.5.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:00:00Z","timestamp":1763596800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Type 2 diabetes mellitus (T2DM), a chronic metabolic disorder requiring sustained glycemic control to prevent complications. Traditional in-clinic care often limits patient engagement to periodic visits, leaving gaps in continuous diabetes management. Digital health interventions, including virtual two way patient engagement between patients and the care team may enhance adherence and outcomes. However, the impact of different engagement modalities on glycemic control remains underexplored. This study evaluates the impact of virtual patient engagement within the GluCare hybrid care model on glycemic control in individuals with T2DM.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This retrospective observational study included T2DM patients(n=125) enrolled in GluCare\u2019s hybrid care program. Participants were stratified into two groups based on glycemic control: controlled (HbA1c &amp;lt;7%) and poorly controlled (HbA1c \u22657%). Patient engagement was categorized into inbound (patient-initiated) and outbound (provider-initiated) interactions. Clinical and metabolic parameters, including HbA1c, blood pressure, lipid profile, inflammatory markers, renal function, and anthropometric measures, were assessed at baseline and 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Participants in the poorly controlled group exhibited a mean HbA1c reduction of \u22122.4% (p &amp;lt; 0.001), while controlled patients improved \u22120.3% (p &amp;lt; 0.001). This magnitude exceeds the \u22120.3% to \u22120.5% typically reported for digital-only interventions, indicating clinically meaningful improvement. The higher number of virtual interactions was associated with improved glycemic control (\u03b2 = \u20130.007; 95% CI: \u20130.011 to \u20130.002; p = 0.003) and remained significant after adjusting for age, BMI, medication use, and glycemic control group (\u03b2 = \u20130.006; 95% CI: \u20130.010 to \u20130.002; p = 0.001). Both controlled and poorly controlled groups achieved similar HbA1c levels at 12 months (p = 0.205). Engagement peaked at 3 months and declined thereafter, with outbound interactions consistently exceeding inbound ones However, Poorly controlled group more prescribed on GIP\/GLP-1 receptor agonists (59.6%), insulin (75%) and statin therapy (56.8%) compared to the controlled group.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Virtual patient engagement, particularly provider-initiated interactions, plays a crucial role in optimizing glycemic control and improving metabolic outcomes in T2DM. Hybrid care models that integrate continuous remote monitoring with periodic in-clinic visits offer a viable approach to sustaining patient adherence.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1695381","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T05:12:34Z","timestamp":1763615554000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Impact of virtual patient engagement on glycemic control in type 2 diabetes: a retrospective observational study from GluCare hybrid care model"],"prefix":"10.3389","volume":"16","author":[{"given":"Hala","family":"Zakaria","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geethu","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joelle","family":"Debs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juman","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Almarzooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ihsan","family":"Almarzooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,11,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30058-2","article-title":"Type 2 diabetes","volume":"389","author":"Chatterjee","year":"2017","journal-title":"Lancet"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00045.2011","article-title":"Mechanisms of diabetic complications","volume":"93","author":"Forbes","year":"2013","journal-title":"Physiol Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S002","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"B5","doi-asserted-by":"publisher","first-page":"BMI.S38440","DOI":"10.4137\/BMI.S38440","article-title":"Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic Patients","volume":"11","author":"Sherwani","year":"2016","journal-title":"biomark Insights"},{"key":"B6","doi-asserted-by":"publisher","first-page":"108072","DOI":"10.1016\/j.diabres.2020.108072","article-title":"Global and regional estimates and projections of diabetes-related health expenditure: Results from the International Diabetes Federation Diabetes Atlas","volume":"162","author":"Williams","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"B7","doi-asserted-by":"crossref","DOI":"10.1515\/9783110452440","volume-title":"Patient engagement: A consumer-centered model to innovate healthcare","author":"Graffigna","year":"2015"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2013.0589","article-title":"Mobile phone diabetes project led to improved glycemic control and net savings for Chicago plan participants","volume":"33","author":"Nundy","year":"2014","journal-title":"Health Affairs"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.2337\/ds17-0067","article-title":"2017 National Standards for Diabetes Self-Management Education and Support","volume":"30","author":"Beck","year":"2017","journal-title":"Diabetes Spectr"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806359","article-title":"Long-term follow-up after tight control of blood pressure in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"New Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fcdhc.2022.936752","article-title":"The effectiveness of digital health technologies for patients with diabetes mellitus: a systematic review","volume":"3","author":"Stevens","year":"2022","journal-title":"Front Clin Diabetes Healthc"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e55757","DOI":"10.2196\/55757","article-title":"Digital interventions for self-management of type 2 diabetes mellitus: systematic literature review and meta-analysis","volume":"26","author":"Kerr","year":"2024","journal-title":"J Med Internet Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/01.JAA.0000668828.47294.2a","article-title":"Diabetes self-management education and support in adults with type 2 diabetes: a consensus report of the American Diabetes Association, the Association of Diabetes Care & Education Specialists, the Academy of Nutrition and Dietetics, the American Academy of Family Physicians, the American Academy of PAs, the American Association of Nurse Practitioners, and the American Pharmacists Association","volume":"60","author":"Powers","year":"2020","journal-title":"J Am Pharmacists Assoc"},{"key":"B14","article-title":"Digital Diabetes Management Solutions","year":"2024"},{"key":"B15","doi-asserted-by":"publisher","first-page":"CAT. 24.0020","DOI":"10.1056\/CAT.24.0020","article-title":"A Hybrid Care Model to Manage Diabetes Mellitus in the United Arab Emirates","volume":"5","author":"Almarzooqi","year":"2024","journal-title":"NEJM Catalyst Innov Care Deliv"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2024.1355792","article-title":"Measuring the effectiveness of hybrid diabetes care over 90 days through continuous data monitoring in type 2 diabetic patients","volume":"15","author":"Zakaria","year":"2024","journal-title":"Front Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"100262","DOI":"10.1016\/j.metop.2023.100262","article-title":"Effectiveness of a hybrid technology enabled care model as measured by ICHOM standard set on established and managed type 2 diabetes already using medications: a RWE retrospective study","volume":"20","author":"Almarzooqi","year":"2023","journal-title":"Metab Open"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.2337\/dc22-S005","article-title":"5. Facilitating behavior change and well-being to improve health outcomes: Standards of Medical Care in Diabetes\u20142022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1177\/1932296817713506","article-title":"A systematic review of reviews evaluating technology-enabled diabetes self-management education and support","volume":"11","author":"Greenwood","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1974","article-title":"Type 2 diabetes in the real world: the elusive nature of glycemic control","volume":"40","author":"Edelman","year":"2017","journal-title":"Diabetes Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2196\/23646","article-title":"Telemedicine via continuous remote care: a proactive, patient-centered approach to improve clinical outcomes","volume":"6","author":"Hallberg","year":"2021","journal-title":"JMIR Diabetes"},{"key":"B23","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/s41746-024-01063-2","article-title":"Characterising user engagement with mHealth for chronic disease self-management and impact on machine learning performance","volume":"7","author":"Duckworth","year":"2024","journal-title":"NPJ Digital Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1695381\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T05:12:35Z","timestamp":1763615555000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1695381\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,20]]},"references-count":23,"alternative-id":["10.3389\/fendo.2025.1695381"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1695381","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,20]]},"article-number":"1695381"}}